SEC Tracker
Get the app
LRMR · XBRL financial data

Larimar Therapeutics financial statements, every quarter

The same tables from 12 filings, lined up. Matched by XBRL tag: renamed lines keep their history.

Download Excel Download CSV
How these numbers work
  • Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
  • Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
  • * marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
  • 0 means a filing states zero; a dash (—) means no filing states that number.
  • “year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
  • Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
  • Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
  • Shares outstanding come from each filing's cover page, as of the date printed there.
  • Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.

Income statement

CSV

Fiscal quarters (LRMR's year ends in late December)

In thousands of dollarsSep 30, 2023Dec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
Research and development6,58510,648*12,93919,68213,91926,738*26,55223,36844,93159,373*25,03128,000
General and administrative3,7543,514*3,7954,9174,3454,555*4,6364,4244,5684,645*6,0866,351
Total operating expenses10,33914,162*16,73424,59918,26431,293*31,18827,79249,49964,018*31,11734,351
Operating income (loss)(10,339)(14,162)*(16,734)(24,599)(18,264)(31,293)*(31,188)(27,792)(49,499)(64,018)*(31,117)(34,351)
Income tax expense (benefit)—year only—000*—000*——
Net income (loss)(9,064)(12,993)*(14,654)(21,627)(15,499)(28,824)*(29,281)(26,182)(47,712)(62,498)*(29,613)(32,782)
Earnings per share, basic USD per share(0.21)(0.30)*(0.27)(0.34)(0.24)(0.45)*(0.46)(0.41)(0.61)———
Earnings per share, diluted USD per share(0.21)(0.30)*(0.27)(0.34)(0.24)(0.45)*(0.46)(0.41)(0.61)———
Weighted average shares, basic thousands of shares43,90443,906*53,55463,80263,80663,807*63,96464,02878,325———
Weighted average shares, diluted thousands of shares43,90443,906*53,55463,80263,80663,807*63,96464,02878,325———

Balance sheet

CSV

Fiscal quarters (LRMR's year ends in late December)

In thousands of dollarsSep 30, 2023Dec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
Cash and cash equivalents38,72126,749110,12532,31135,06733,21821,12620,58790,14085,412177,91392,687
Marketable securities56,86960,041117,171193,753168,640150,236136,400117,93785,29551,44022,47263,580
Marketable securities, non-current——11,711—————————
Prepaid and other current assets2,8903,3853,6575,0669,54911,8507,9597,0327,7885,1704,5924,405
Total current assets98,48090,175230,953231,130213,256195,304165,485145,556183,223142,022204,977160,672
Property and equipment, net601684604844779881855797709622558639
Right-of-use asset2,8983,0782,9203,2133,0262,8382,6472,4682,2702,0691,8663,055
Total assets103,95295,935248,205237,162219,021200,225170,175149,988187,350145,842208,511165,302
Accounts payable7561,2831,9182,9171,6862,4242,2744,16911,1005,2168,5767,597
Accrued liabilities5,0947,38610,09817,24613,57320,87218,76421,35132,86558,47438,12325,367
Total current liabilities6,5589,50612,84121,15516,28524,35622,13426,64945,11664,79547,75734,166
Lease liability, non-current4,6824,7094,5204,6034,3364,0573,7703,4853,1962,9622,7213,754
Total liabilities11,24014,21517,36125,75820,62128,41325,90430,13448,31267,75750,47837,920
Accumulated deficit(175,561)(188,554)(203,208)(224,835)(240,334)(269,158)(298,439)(324,621)(372,333)(434,831)(464,444)(497,226)
Total stockholders' equity92,71281,720230,844211,404198,400171,812144,271119,854139,03878,085158,033127,382
Total liabilities and equity103,95295,935248,205237,162219,021200,225170,175149,988187,350145,842208,511165,302
Common shares outstanding (cover page) thousands of shares43,90663,80063,80263,80763,80764,02864,02885,59085,590103,883103,883103,883

Cash flows

CSV

Fiscal quarters (LRMR's year ends in late December)

In thousands of dollarsSep 30, 2023Dec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
Net income (loss)(9,064)(12,993)*(14,654)(21,627)(15,499)(28,824)*(29,281)(26,182)(47,712)(62,498)*(29,613)(32,782)
Stock-based compensation1,821*1,918*2,1282,301*1,957*2,410*1,8341,828*1,785*1,557*1,9792,149*
Net cash from operating activities(9,200)*(9,343)*(10,411)(13,988)*(24,546)*(21,815)*(26,540)(19,381)*—year only(44,614)(44,030)*
Purchases of property and equipment—year only——62*179*4919*23*0*——
Net cash from investing activities(46,430)*(2,629)*(68,364)(63,492)*27,272*19,197*14,44818,842*—year only29,000(40,911)*
Proceeds from issuing common stock—————0*———(201)*——
Proceeds from issuing equity——162,151(345)*0*—————108,101(435)*
Net cash from financing activities—0*162,151(334)*30*36*———year only108,115(435)*
Net change in cash(55,600)*(11,972)*83,376(77,814)*2,756*(2,582)*(12,092)(539)*69,553*(4,728)*92,501(85,376)*

Compare with peers

The peer list for this company is being put together from its industry's latest filings. Reload the page in a minute to see it.

Not investment advice. Not affiliated with the U.S. SEC.